BioTech 365

SEPTEMBER 20, 2021

Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & Reagents), Technique (Promoter Analysis, RNA Exp.) – ResearchAndMarkets.com Global Gene Expression Market Size, Share & Trends Analysis 2021-2028 by Product (DNA Chip/Microarray, Kits & … Continue reading → (..)

Gene Expression 40

Gene Expression Reagent DNA RNA 40

Medical Xpress

FEBRUARY 9, 2023

When cells copy DNA to produce RNA transcripts, they include only some chunks of genetic material known as exons and throw out the rest. The resulting product is a fully-mature RNA molecule, which can be used as a template to build a protein.

RNA 75

RNA DNA Gene Genetics 75

BioTech 365

AUGUST 10, 2020

$2,950.00End Date: Monday Aug-31-2020 14:55:52 PDTBuy It Now for only: $2,950.00Buy It Now | Add to watch list Biotech365 : NEW Thermo Invitrogen Qubit 4 DNA RNA Oligo Ion Protein Fluorometer w/Warranty BioMarketplace You want to propose your products or … Continue reading →

RNA 40

RNA DNA Protein Production 40

XTalks

JANUARY 21, 2025

The Shield test provides a non-invasive approach to colorectal cancer screening by analyzing blood for key DNA changes linked to cancer. There, plasma is separated, and tumor DNA is identified by detecting genetic mutations, methylation patterns and fragmentation signals. The Onclarity HPV reagent pack extraction combo.

FDA Approval 105

FDA Approval Manufacturing Development RNA 105

The Pharma Data

JANUARY 5, 2021

Durham, North Carolina-based Ribometrix announced a strategic collaboration deal with Genentech , a Roche company, to identify and advance novel RNA-targeted small molecule therapeutics. Targeting RNA is believed to be a way to develop therapeutics for so-called undruggable proteins. The first identifies the 3D RNA motifs.

RNA 52

RNA Protein Bioavailability DNA 52

XTalks

AUGUST 10, 2021

A porous membrane was engineered to capture RNA on its surface. A CRISPR-based reaction generates a fluorescent signal in the presence of SARS-CoV-2 viral RNA in a saliva sample. The device costs about $15, but mass production would bring the housing costs down to about $3. Image source: Wyss Institute at Harvard University.

RNA 105

RNA Containment DNA Engineer 105

Pharmaceutical Technology

FEBRUARY 23, 2023

The company will also receive tiered royalties on the worldwide net sales of products developed from the collaboration. The gene editing platform of Life Edit provides an extensive and diverse library of base editors and RNA-guided nucleases (RGNs), which are smaller in size than conventional nucleases.

Gene Editing 147

Gene Editing Gene In-Vivo Gene Therapy 147

BioTech 365

NOVEMBER 11, 2021

c-LEcta Expands Product Range to Include Additional Enzyme NuCLEANase® c-LEcta Expands Product Range to Include Additional Enzyme NuCLEANase® New enzyme product NuCLEANase® allows for the degradation of all types of DNA/RNA Efficient, robust and economical solution for industrial processes in … Continue reading →

Production 40

Production RNA DNA 40

XTalks

AUGUST 9, 2022

The test achieves its speed in two ways: a new RNA to DNA conversion step designed by Dr. Dafforn and his research team that avoids reverse transcription, and an alternative DNA amplification process (EXPAR). In addition, EXPAR amplifies DNA at a single temperature as opposed to the lengthy heating and cooling steps in PCR.

Licensing 98

Licensing Licensing DNA RNA 98

Roots Analysis

FEBRUARY 21, 2022

Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine. Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production. NGS Service Providers.

Marketing 52

Marketing Gene Sequencing DNA Genomics 52

Roots Analysis

FEBRUARY 23, 2022

Over the past few years, several companies have started offering a diverse range of genome sequencing products and services using various second and third generation sequencing technologies. Currently, close to 60 industry players are actively offering NGS kits for preparing DNA / RNA libraries. Players Engaged in the Domain.

Genetics 52

Genetics DNA RNA Reagent 52

pharmaphorum

OCTOBER 2, 2020

Vaccibody, which is also entitled to tiered royalties on sales of any marketed products, will develop the DNA-based individualised neoantigen vaccines until the end of phase 1b. Vaccibody has been working on a targeted DNA-based vaccine platform, in a bid to find a potential new treatment paradigm for individualised cancer vaccines.

Vaccine 59

Vaccine Vaccination Immune Response Drugs 59

XTalks

FEBRUARY 11, 2021

Pfizer is planning to reduce that time to an average of 60 days, cutting production time by almost 50 percent. For Pfizer-BioNTech’s vaccine, a batch consists of between one and three million doses of vaccine per production run. This in light of Pfizer having upped its production goal to two billion COVID-19 vaccine doses this year.

Manufacturing 52

Manufacturing Vaccine Vaccination DNA 52

The Pharma Data

OCTOBER 19, 2020

Spectrum’s self-contained saliva collection kit provides critical sample consistency while suspending and neutralizing viral RNA transcripts completely inactivating the live virus. Qualified commercial RNA extraction chemistries include Perkin Elmer, Thermo Fisher, Roche, and Qiagen. ABOUT SPECTRUM SOLUTIONS AND SPECTRUM DNA.

RNA 52

RNA DNA Engineer Packaging 52

Worldwide Clinical Trials

JUNE 15, 2022

Further, some patients are still hesitant to go into the clinic, and the prevalence of misinformation from the pandemic has led to greater concerns about therapies like gene therapies and the impact they fear it will have on their RNA/DNA.

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

Roots Analysis

MARCH 16, 2023

Messenger ribonucleic acid (mRNA) is a single-stranded molecule that is complementary to a gene’s DNA. It is important in the process of protein synthesis because mRNA is responsible for transferring genetic information from DNA to ribosomes, which then decodes the genetic information into a protein.

Vaccine 52

Vaccine Vaccination DNA Protein 52

Roots Analysis

AUGUST 12, 2024

Molecular diagnostic tests refer to tests intended to detect specific sequences in human genomic samples, such as DNA or RNA, in order to diagnose a particular disease. According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market. What are Molecular Diagnostic Tests?

Genetics 40

Genetics Gene Expression RNA DNA 40

The Pharma Data

NOVEMBER 22, 2020

The product is the most advanced gene-editing approach in development for transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease. Cas-9 represents the Cas9 protein, an enzyme that cuts foreign DNA. Once the DNA has been cut, the cell’s natural repair mechanisms kick in.

Gene Editing 52

Gene Editing DNA Genomics Genome 52

Roots Analysis

FEBRUARY 18, 2022

In the 20 th century, major research went into discovery of a therapeutic class with the primary purpose of interfering with the RNA expression linked to disease causing proteins, nowadays classified as oligonucleotides. For further information on this domain, check out the report –. Our Social Media Platform. Web: [link].

Contract Manufacturing 52

Contract Manufacturing Manufacturing Drug Delivery Systems RNA 52

Roots Analysis

AUGUST 28, 2022

As a result, industry and non-industry stakeholders, are on the lookout for advanced platforms that can simultaneously capture the arrangement of multiple biomolecules (DNA, RNA, proteins and others) with single-cell or subcellular resolution.

Genomics 52

Genomics Genome RNA Genome Project 52

Pharmaceutical Technology

MARCH 8, 2023

The aggregate strength of our platform, which provides patient level DNA and RNA data both in tissue and blood, may help to better identify and predict patient response to therapy, which, in turn, may accelerate clinical trial enrolment, optimise clinical positioning and potentially enhance technical and regulatory success.”

Research 130

Research Clinical Trials Clinical Trials Life Science 130

Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. Due to their size, cells can absorb them where they release products. Langer, now a David H. Still, several established challenges remain.

Drug Delivery 147

Drug Delivery Vaccine Vaccination Research 147

XTalks

JANUARY 8, 2024

About 70 percent or more of data that’s submitted to get a drug approved is lab data, and that’s how we show efficacy and safety for a particular product.” – Cindy Markham LabConnect employs several technologies and services to support this. They utilize digital pens and scanning systems to track samples meticulously.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Gene Therapy 105

Delveinsight

JANUARY 14, 2021

The study’s primary result will be the proportion of patients attaining a functional treatment, defined as an off-therapy loss of hepatitis B surface antigen (HBsAg) and HBV DNA from the serum. The treatment, VERVE-101, is a base editor; that is, it does not cut DNA as CRISPR gene editing systems do.

Gene Editing 40

Gene Editing Gene Genetics DNA 40

The Pharma Data

NOVEMBER 5, 2020

In August, the company announced that it had entered a clinical collaboration agreement with Arbutus Biopharma Corporation to evaluate the product, in combination with Arbutus’ proprietary GalNAc delivered RNAi therapeutic AB-729 and NrtI therapy, for the treatment of chronic hepatitis B virus infection.

Drugs 40

Drugs Clinical Trials Clinical Trials RNA 40

The Pharma Data

JANUARY 13, 2021

” The Johnson & Johnson vaccine also would be hardier than either of the already approved vaccines because it relies on DNA technology rather than messenger RNA to prompt an immune system response. If you only have to give one dose, that would be great.” © 2021 HealthDay. All rights reserved.

Vaccine 40

Vaccine Vaccination Trials Immune Response 40

The Pharma Data

OCTOBER 21, 2020

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency’s (EMA) recently issued a positive opinion recommending marketing authorisation for long-acting cabotegravir and rilpivirine in both injectable and tablet formulations.

Clinical Development 52

Clinical Development Development Medicine Clinical Trials 52

The Pharma Data

SEPTEMBER 1, 2020

In general, antigen tests have a high specificity, though are not as sensitive as molecular tests that amplify the target viral DNA or RNA sequence in order to generate a quantifiable signal to indicate the presence of the virus in a sample.

In-Vitro 52

In-Vitro Antibody Medicine Clinical Trials 52

The Pharma Data

SEPTEMBER 6, 2021

Roche’s Chief Medical Officer and Head of Global Product Development. Fusion and rearrangement (RE) detection using DNA and RNA-based comprehensive genomic profiling (CGP) of sarcomas. Baseline mutational profiles of patients (pts) with carcinoma-of-unknown-primary-origin (CUP) enrolled onto CUPISCO.

Genomics 52

Genomics Genome HR Hormones 52

Camargo

JULY 27, 2021

It is a comprehensive term which encompasses a large variety of therapy products including viral and bacterial vectors, plasmid DNA, human gene editing technology, and patient-specific cellular gene therapy. Gene therapy is a new therapeutic approach in which genes are used to treat or prevent diseases. Formulation Considerations.

Gene Therapy 238

Gene Therapy Gene Gene Editing Genetics 238

The Pharma Data

APRIL 30, 2021

“Our new products are delivering impressive performance and we are on the cusp of potential commercial approvals for more than a dozen new products or indications over the next two years – including five expected approvals in 2021.” Refer to the Key Product Revenues schedules for further details. to $7.47.

Botox 40

Botox Production Development Cosmetics 40

Roots Analysis

OCTOBER 22, 2023

RNA therapeutics are a novel class of biopharmaceuticals that harness the power of RNA molecules for the treatment and prevention of a wide range of disorders, including oncological, and genetic disorders as well as infectious diseases. Non-coding RNAs include antisense oligonucleotides (ASOs) and RNA aptamers.

RNA 40

RNA Protein Genetics Gene Expression 40

Pharmaceutical Technology

MARCH 9, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. Oligonucleotides is used to block the production of proteins needed for cell growth.

RNA 130

RNA DNA Antibody Production 130

Pharmaceutical Technology

FEBRUARY 3, 2023

Since HIV integrates with the DNA, eliminating the virus from the body is very difficult, explains David Montefiori, PhD, director of the Laboratory for AIDS Vaccine Research and Development at Duke University in Durham, North Carolina. The failure of several late-stage trials highlights the challenging nature of HIV vaccine development.

Vaccine 293

Vaccine Vaccination Antibody Trials 293

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These viruses carry the genetic information to synthesise an RNA-dependent RNA polymerase.

RNA 240

RNA Genetics Vaccine Vaccination 240

pharmaphorum

JANUARY 6, 2021

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. Encoded within a successful emblem is a company’s DNA – its history, its future.

DNA 116

DNA Branding Vaccine Vaccination 116

Pharmaceutical Technology

JUNE 4, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Genetics 130

Genetics Gene Expression DNA Antibody 130